USE OF XANTHOHUMOL AND ISOXANTHOHUMOL AS ACTIVE SUBSTANCE FOR PREVENTING AND/OR CONTROLLING LIVER DISEASES Russian patent published in 2012 - IPC A61K31/121 A61K36/00 A61P1/16 A61P3/04 A61P39/06

Abstract RU 2454996 C2

FIELD: medicine.

SUBSTANCE: group of inventions refers to medicine and aims at preventing and treating a liver diseases. What is used is xanthohumol of formula (I) or xanthohumol metabolite as an active substance for making a preparation for preventing and/or controlling the liver diseases caused by obesity and/or diabetes. The daily dose varies within 0.01 to 161 mg/kg of weight. The xanthohumol content in the composition makes 0.1 to 99 wt %.

EFFECT: group of inventions allows having an effect on viral replication and cancer cell apoptosis, delaying developing cirrhosis.

25 cl, 10 dwg, 2 ex

Similar patents RU2454996C2

Title	Year	Author	Number
HOP EXTRACT	2007	Onikienko Boris Sergeevich Onikienko Sergej Borisovich Zemljanoj Aleksandr Vasil'Evich Fosman Arkadij Valer'Evich	RU2344167C2
SOLUBILISATE WITH CURCUMIN AND AT LEAST ONE THC CANNABINOID AS AN ADDITIONAL ACTIVE SUBSTANCE	2019	Behnam, Dariush	RU2777185C1
SOLUBILIZE WITH CURCUMIN, AND IF NECESSARY AT LEAST WITH ONE OTHER ACTIVE SUBSTANCE	2018	Behnam, Dariush	RU2752078C1
USING LACTITOL AND AN ORAL DOSAGE FORM FOR TREATING AND PREVENTING NON-ALCOHOLIC FATTY LIVER DISEASE	2018	Nesteruk Vladimir Viktorovich Syrov Kirill Konstantinovich	RU2692243C1
HEPATOPROTECTIVE AND ANTIHEPATOTOXIC PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING HEPATIC DISEASES THAT INVOLVES INTRODUCTION OF SAID COMPOSITION	2008	Kozhoka Timofej Georgievich Jasinskij Sergej Jaroslavovich	RU2381800C1
METHOD OF IMPROVEMENT OF LIVER FUNCTION	2013	Uolder Ken Krippner Gaj Nikolson Dzhoff	RU2653478C2
THERAPEUTIC AND DIETETIC COMPOSITIONS CONTAINING ESSENTIAL FATTY ACIDS AND BIOLOGICALLY ACTIVE DISULFIDES	1998	Khorrobin Dehvid Frederik Trichler Khans-Jurgen	RU2205004C2
SOLUBILISATE WITH CURCUMIN AND AT LEAST ONE CANNABINOID AS AN ADDITIONAL ACTIVE SUBSTANCE	2019	Behnam, Dariush	RU2771527C1
COMPOSITION FOR IMPROVING OR PREVENTING NON-ALCOHOLIC FATTY LIVER DYSTROPHY	2016	Kessoku, Takaomi Nakajima, Atsushi Sumida, Yoshio Eguchi, Yuichiro Saito, Susumu Sauchi, Yusuke	RU2746091C2
USE OF VAP-1 INHIBITORS FOR FIBROTIC SICKNESS TREATMENT	2010	Veston Kristofer Klaridzh Li Charlz Adams Devid Smit Devid Vesterlund Nina Pikhlavisto Maro Esterman Tua	RU2580626C2

RU 2 454 996 C2

Authors

Khellerbrand Klaus

Dates

2012-07-10—Published

2007-12-21—Filed